CA Patent

CA2872260C — Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Assigned to Corcept Therapeutics Inc · Expires 2020-12-22 · 5y expired

What this patent protects

The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

USPTO Abstract

The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Drugs covered by this patent

Mifeprex (MIFEPRISTONE) · Corcept Therap

Patent Metadata

Patent number: CA2872260C
Jurisdiction: CA
Classification: —
Expires: 2020-12-22
Drug substance claim: No
Drug product claim: No
Assignee: Corcept Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.